GLP-1 drugs show promise in reducing cancer risk across multiple types, with effects beyond weight loss. Studies suggest anti-inflammatory benefits may suppress tumors. Researchers are investigating mechanisms through new trials, though current evidence remains correlative and requires further validation.
GLP-1 Drugs May Significantly Reduce Cancer Risk
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →